Report data readout from Versamune HPV neoadjuvant trial in oropharynx cancer
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 5 Feb 2025
- Due
- 31 Mar 2026
- Delivered
- 2 Jun 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Data readout: Versamune® HPV and Versamune® HPV + Pembrolizumab as neoadjuvant in HPV16+ oropharynx cancer”
What we found
Evidence strength B What the grades mean
PDS Biotech presented initial neoadjuvant Versamune HPV (+/- pembrolizumab) oropharynx cancer trial (MC200710) data at ASCO on June 2, 2025, well ahead of the Q1 2026 deadline.
-
B PDS Biotech Announces Positive Extended Follow-Up Data for VERSATILE-002 and Additional Trials Press release detailing MC200710 neoadjuvant trial results to be presented at ASCO 2025.
-
C PDS Biotech Announces Multiple Abstracts Selected for Presentation at the 2025 ASCO Annual Meeting Confirms MC200710 neoadjuvant data poster scheduled for June 2, 2025.
-
D Initial results of MC200710 ... phase 2 window of opportunity trial Published abstract with primary endpoint results for the neoadjuvant HPV16+ oropharynx trial.
Checked 18 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
How this entry was checked
- Commitment recordedRecorded from the company's filing.
- First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you PDS Biotechnology Corp? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-PDSB-000203 · Corrections policy